Nonadherence in outpatient thromboprophylaxis after major orthopedic surgery: a systematic review

References

• Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. Lancet358, 9–15 (2001).
   PubMed Web of Science ®Google Scholar
• Hull RD, Pineo GF, Stein PD et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann. Intern. Med.135(10), 858–869 (2001).
   PubMed Web of Science ®Google Scholar
• Kolb G, Bodamer I, Galster H et al. Reduction of venous thromboembolism following prolonged prophylaxis with the low molecular weight heparin certoparin after endoprothetic joint replacement or osteosynthesis of the lower limb in elderly patients. Thromb. Haemost.90(6), 1100–1105 (2003).
   PubMed Web of Science ®Google Scholar
• Kakkar AK, Brenner B, Dahl OE et al. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. Lancet372(9632), 31–39 (2008).
   PubMed Web of Science ®Google Scholar
• Geerts WH, Bergqvist DF, Pineo G et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest133, 381–453 (2008).
   PubMed Web of Science ®Google Scholar
• Haentjens P, De Groote K, Annemans L. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost–utility analysis. Arch. Orthop. Trauma Surg.124(8), 507–517 (2004).
   PubMed Web of Science ®Google Scholar
• Bischof M, Leuppi JD, Sendi P. cost–effectiveness of extended venous thromboembolism prophylaxis with fondaparinux in hip surgery patients. Expert Rev. Pharmacoecon. Outcomes Res.6(2), 171–180 (2006).
   PubMedGoogle Scholar
• Skedgel C, Goeree R, Pleasance S, Thompson K, O’Brien B, Anderson D. The cost–effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty. J. Bone Joint Surg. Am.89(4), 819–828 (2007).
   PubMed Web of Science ®Google Scholar
• Huo MH, Muntz J. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. Clin. Ther.31(6), 1129–1141 (2009).
   PubMedGoogle Scholar
• Amin AN, Lin J, Ryan A. Need to improve thromboprophylaxis across the continuum of care for surgical patients. Adv. Ther.27(2), 81–93 (2010).
   PubMed Web of Science ®Google Scholar
• Borris LC. Barriers to the optimal use of anticoagulants after orthopaedic surgery. Arch. Orthop. Trauma Surg.129(11), 1441–1445 (2009).
   PubMed Web of Science ®Google Scholar
• Eriksson BI, Dahl OE, Rosencher N et al. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J. Thromb. Haemost.11, 2178–2185 (2007).
   Google Scholar
• Eriksson BI, Kakkar AK, Turpie AG et al. Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J. Bone Joint Surg. Br.91(5), 636–644 (2009).
   PubMed Web of Science ®Google Scholar
• Friedman RJ, Dahl OE, Rosencher N et al. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb. Res.126(3), 175–182 (2010).
   PubMed Web of Science ®Google Scholar
• Wolowacz SE, Roskell NS, Plumb JM, Caprini JA, Eriksson BI. Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty: a meta-analysis. Thromb. Haemost.101, 77–85 (2009).
   PubMed Web of Science ®Google Scholar
• Wolowacz SE, Roskell NS, Maciver F et al. Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery. Clin. Ther.31(1), 194–212 (2009).
   PubMed Web of Science ®Google Scholar
• Wilke T. Patient preferences for an oral anticoagulant after major orthopaedic surgery: results of a German survey. Patient2, 39–49 (2009).
   PubMedGoogle Scholar
• OECD Health Data. Average Length of Stay by Diagnostic Categories (CD-Rom). OECD Publishing, Paris, France (2009).
   Google Scholar
• Wilke T, Moock J, Müller S, Pfannkuche M, Kurth A. Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery. Clin. Orthop. Relat. Res.468(9), 2437–2453 (2010).
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N. Engl. J. Med.353, 487–497 (2005).
   PubMed Web of Science ®Google Scholar
• Liu H, Miller HG, Hays RD et al. A comprehensive evaluation of survey questions for adherence to antiretroviral medications and exploratory analyses for identifying optimal sets of survey questions. AIDS Patient Care STDS20, 760–772 (2006).
   PubMed Web of Science ®Google Scholar
• Karve S, Cleves MA, Helm M, Hudson TJ, West D, Martin BC. Good and poor adherence: optimal cut-point for adherence measures using administrative claims data. Curr. Med. Res. Opin.25(9), 2303–2310 (2009).
   PubMed Web of Science ®Google Scholar
• Bjørnarå BT, Gudmundsen TE, Dahl OE. Frequency and timing of clinical venous thromboembolism after major joint surgery. J. Bone Joint Surg. Br.88, 386–391 (2006).
   PubMed Web of Science ®Google Scholar
• Arcelus JI, Kudrna JC, Caprini JA. Venous thromboembolism following major orthopaedic surgery: what is the risk after discharge? Orthopaedics29(6), 506–516 (2006).
   PubMedGoogle Scholar
• Watts AC, Howie CR, Simpson AH. Assessment of a self-administration protocol for extended subcutaneous thromboprophylaxis in lower limb arthroplasty. J. Bone Joint Surg. Br.88(1), 107–110 (2006).
   PubMedGoogle Scholar
• Karliński M, Stolarczyk A, Siuda M, Ziólkowski M. Compliance with low molecular weight heparin in ambulatory orthopaedic patients. Ortop. Traumatol. Rehabil.8, 633–638 (2006).
   PubMedGoogle Scholar
• Spahn G. Compliance with self-administration of heparin injections in outpatients. Eur. J. Trauma28(2), 104–109 (2002).
   Google Scholar
• Le Gall C, Jacques E, Medjebeur C et al. Low molecular weight heparin self-injection training: assessment of feasibility, tolerance and economic analysis in emergency departments. Eur. J. Emerg. Med.13, 264–269 (2006).
   PubMedGoogle Scholar
• Colwell CW Jr, Pulido P, Hardwick ME, Morris BA. Patient compliance with outpatient prophylaxis: an observational study. Orthopaedics28, 143–147 (2005).
   PubMed Web of Science ®Google Scholar
• Peterson AM, Nau D, Cramer JA, Benner J, Gwadry-Sridhar F, Nichal M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health10(1), 3–12 (2007).
   PubMed Web of Science ®Google Scholar
• Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. (2), CD000011 (2008).
   Google Scholar
• Dailey G, Kim MS, Lian JF. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of Type 2 diabetic patients. J. Int. Med. Res.30, 71–79 (2002).
   PubMed Web of Science ®Google Scholar
• Friedman RJ, Gallus AS, Cushner FD, Fitzgerald G, Anderson FA Jr; Global Orthopaedic Registry Investigators. Physician compliance with guidelines for deep-vein thrombosis prevention in total hip and knee arthroplasty. Curr. Med. Res. Opin.24, 87–97 (2008).
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Karthikeyan G, Fagel N, Hirsh J. American Association of Orthopaedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients? Chest135(2), 513–520 (2009).
   PubMed Web of Science ®Google Scholar
• Le Sage S, McGee M, Emed JD. Knowledge of venous thromboembolism (VTE) prevention among hospitalized patients. J. Vasc. Nurs.26(4), 109–117 (2008).
   PubMedGoogle Scholar
• Marks JR, Schectman JM, Groninger H, Plews-Ogan ML. The association of health literacy and socio-demographic factors with medication knowledge. Patient Educ. Couns.78(3), 372–376 (2010).
   PubMed Web of Science ®Google Scholar
• Gazmararian JA, Kripalani S, Miller MJ, Echt KV, Ren J, Rask K. Factors associated with medication refill adherence in cardiovascular-related diseases: a focus on health literacy. J. Gen. Intern. Med.21(12), 1215–1221 (2006).
   PubMed Web of Science ®Google Scholar
• Kistler U, Kramers-de Quervain I, Munzinger U, Kucher N. Bleeding complications after systematic switch of routine thromboprophylaxis for major orthopaedic surgery. Thromb. Haemost.99(6), 1049–1052 (2008).
   PubMedGoogle Scholar
• Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med. Care24(1), 67–74 (1986).
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J. Clin. Hypertens. (Greenwich)10, 348–354 (2008).
   PubMed Web of Science ®Google Scholar
• Mahler C, Hermann K, Horne R et al. Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany. J. Eval. Clin. Pract.16(3), 574–579 (2010).
   PubMed Web of Science ®Google Scholar
• Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Prog. Cardiovasc. Nurs.15(3), 90–96 (2000).
   PubMedGoogle Scholar
• Kripalani S, Risser J, Gatti ME, Jacobson TA. Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease. Value Health12(1), 118–123 (2009).
   PubMed Web of Science ®Google Scholar
• Hahn SR, Park J, Skinner EP et al. Development of the ASK-20 adherence barrier survey. Curr. Med. Res. Opin.24(7), 2127–2138 (2008).
   PubMed Web of Science ®Google Scholar
• Byerly MJ, Nakonezny PA, Rush AJ. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr. Res.100(1–3), 60–69 (2008).
   PubMed Web of Science ®Google Scholar
• Rofail D, Abetz L, Viala M, Gait C, Baladi JF, Payne K. Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument. Value Health12(1), 109–117 (2009).
   PubMed Web of Science ®Google Scholar
• Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ. Couns.59(1), 13–20 (2005).
   PubMed Web of Science ®Google Scholar
• Rolley JX, Davidson PM, Dennison CR, Ong A, Everett B, Salamonson Y. Medication adherence self-reported instruments: implications for practice and research. J. Cardiovasc. Nurs.23, 497–505 (2008).
   PubMedGoogle Scholar
• Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol. Drug Saf.15, 565–574 (2006).
   PubMed Web of Science ®Google Scholar